NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/04/2021
Back to search
Official data from USPTO
CARDIORENOMAX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CARDIORENOMAX
ST13
US500000079267633Class
44
Filing
79267633
Registration
5987040
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
15
Latest update
12/04/2021
Trademark type
Word
Nice classes
44
Filing date
07/29/2019
Registration date
02/18/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/18/2020
Last transaction
02/18/2020
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
25
Owner location
CH
Examiner
COLLOPY, DIANE
Law office
L70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Vifor Fresenius Medical Care Renal Pharma Ltd. (Vifor Fresenius Medical Care Renal Pharma AG)
Representatives
Isler & Pedrazzini AG
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Medical and veterinary services; hygienic and beauty care for human beings or animals
Publications
History of USPTO decisions and trademark events.
15 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/21/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
04/10/2021
GPNX
NOTIFICATION PROCESSED BY IB
05/01/2020
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
03/31/2020
XXCR
GENERIC MADRID TRANSACTION CREATED
03/31/2020
GPAR
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
03/19/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
02/18/2020
PUBO
PUBLISHED FOR OPPOSITION
12/03/2019
NPUB
NOTICE OF PUBLICATION
11/13/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/28/2019
DOCK
ASSIGNED TO EXAMINER
10/22/2019
MAFR
APPLICATION FILING RECEIPT MAILED
09/28/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/24/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/19/2019
Continuous trademark protection
Get notified about every new filing that threatens CARDIORENOMAX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.